Status
Conditions
Treatments
About
The SIDERA^B telerehabilitation system is enabled by a multi-domain, multi-device platform providing at home multi-component rehabilitation, targeting cardiovascular (Chronic Heart Failure, CHF), pulmonary (Chronic Obstructive Pulmonary Disease, COPD) and neurodegenerative (Parkinson Disease, PD) chronic diseases. The rehabilitation program embeds engagement activities for patient and caregiver, to empower appropriation of the SIDERA^B care routines and fuel their well-being resources.
The multidisciplinary layering of SIDERA^B is reflected in the validation protocol including a) clinical and well-being evaluation through a cross-over study confronting usual care with the SIDERA^B activities; b) technological evaluation: Health Technology Assessment for organizational, legal and equity impacts; c) economic evaluation: process mapping and budget impact analysis to define a sustainable reimbursement process for the innovative telerehabilitation pathway.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
agreement to participate, with the signature of the informed consent form.
availability of a caregiver/study partner, who agrees to support the participant through the SIDERA^B program.
living in one's own home.
clinical diagnosis of Chronic Heart Failure (CHF) and
clinical diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and
clinical diagnosis of Parkinson Disease (PD) and
age between 18 and 85 years.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal